Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$18.1 million.

  • Maravai Lifesciences Holdings' Free Cash Flow fell 49771.18% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.3 million, marking a year-over-year decrease of 51901.07%. This contributed to the annual value of -$22.2 million for FY2024, which is 13657.93% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Free Cash Flow stood at -$18.1 million for Q3 2025, which was down 49771.18% from -$13.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Free Cash Flow registered a high of $162.6 million during Q2 2022, and its lowest value of -$20.5 million during Q4 2024.
  • In the last 5 years, Maravai Lifesciences Holdings' Free Cash Flow had a median value of $7.9 million in 2024 and averaged $45.5 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Free Cash Flow surged by 178646.56% in 2021 and then crashed by 49771.18% in 2025.
  • Maravai Lifesciences Holdings' Free Cash Flow (Quarter) stood at $53.1 million in 2021, then skyrocketed by 75.41% to $93.1 million in 2022, then crashed by 109.67% to -$9.0 million in 2023, then plummeted by 127.41% to -$20.5 million in 2024, then increased by 11.77% to -$18.1 million in 2025.
  • Its Free Cash Flow was -$18.1 million in Q3 2025, compared to -$13.1 million in Q2 2025 and -$14.6 million in Q1 2025.